Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Frontiers in Immunology|August 1, 2020
Characterization of a Novel Compound That Stimulates STING-Mediated Innate Immune Activity in an Allele-Specific MannerJinu Abraham, Sara Botto, Nobuyo Mizuno, et al.AIDS (London, England)|October 4, 2023
CD4 dim CD8 bright T cells are inversely associated with neuro-inflammatory markers among people with HIVYasmeen A Albalawi, Tanner Shull, Amber K Virdi, et al.Iscience|October 20, 2023
AP-1/c-Fos supports SIV and HIV-1 latency in CD4 T cells infected in vivoViviana Cobos Jiménez, Aviva Geretz, Andrey Tokarev, et al.The Journal of Biological Chemistry|May 11, 2013
Exosomes derived from HIV-1-infected cells contain trans-activation response element RNAAarthi Narayanan, Sergey Iordanskiy, Ravi Das, et al.Journal of Virology|July 27, 2026
Rapid and robust immune response boosting with potent, next-generation adjuvant in viral vector-primed primatesHannah A D King, Caroline Subra, Emily Tourtellott, et al.Journal of Virology|October 27, 2021
Protective Efficacy of Gastrointestinal SARS-CoV-2 Delivery against Intranasal and Intratracheal SARS-CoV-2 Challenge in Rhesus MacaquesJingyou Yu, Natalie D Collins, Noe B Mercado, et al.Vaccines|May 28, 2022
A SARS-CoV-2 Spike Ferritin Nanoparticle Vaccine Is Protective and Promotes a Strong Immunological Response in the Cynomolgus Macaque Coronavirus Disease 2019 (COVID-19) ModelSara C Johnston, Keersten M Ricks, Ines Lakhal-Naouar, et al.Biorxiv : the Preprint Server for Biology|April 14, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Elakhal Naouar, et al.Biorxiv : the Preprint Server for Biology|April 1, 2021
Efficacy of a Broadly Neutralizing SARS-CoV-2 Ferritin Nanoparticle Vaccine in Nonhuman PrimatesMichael G Joyce, Hannah A D King, Ines Elakhal Naouar, et al.Proceedings of the National Academy of Sciences of the United States of America|September 2, 2021
Efficacy and breadth of adjuvanted SARS-CoV-2 receptor-binding domain nanoparticle vaccine in macaquesHannah A D King, M Gordon Joyce, Ines Lakhal-Naouar, et al.Pageof 3